+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Global Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Autoimmune Treatment Global Market Report 2024 - Product Thumbnail Image

Autoimmune Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
ACVR1 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ACVR1 protein inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
ROI in Pharmaceutical R&D: How to Halt the Decline - Product Thumbnail Image

ROI in Pharmaceutical R&D: How to Halt the Decline

  • Report
  • December 2019
  • 196 Pages
  • Global
From
Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 110 Pages
  • Global
From
Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 80 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 146 Pages
  • Global
From
Influenza Vaccination Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Influenza Vaccination Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2022
  • 72 Pages
  • Global
From
Market Spotlight: Hereditary Angioedema - Product Thumbnail Image

Market Spotlight: Hereditary Angioedema

  • Report
  • March 2021
  • 43 Pages
  • Global
Influenza Drugs and Vaccines Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Influenza Drugs and Vaccines Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2021
  • 102 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 140 Pages
  • Global
From
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2020 - Product Thumbnail Image

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 64 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 127 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Disease - Global Clinical Trials Review, H2 2020 - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Disease - Global Clinical Trials Review, H2 2020

  • Clinical Trials
  • October 2020
  • 123 Pages
  • Global
From
Influenzavirus A Infections - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Influenzavirus A Infections - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • October 2020
  • 403 Pages
  • Global
From
Influenzavirus B Infections Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Influenzavirus B Infections Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • July 2020
  • 151 Pages
  • Global
From
Growth Opportunities in Gene Therapies, Cancer, Disease Treatment & Monitoring, Surgical Applications and Cosmetics - Product Thumbnail Image

Growth Opportunities in Gene Therapies, Cancer, Disease Treatment & Monitoring, Surgical Applications and Cosmetics

  • Report
  • January 2021
  • 40 Pages
  • Global
Activin Receptor Type 1 - Pipeline Review, H1 2020 - Product Thumbnail Image

Activin Receptor Type 1 - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 70 Pages
  • Global
From
Loading Indicator